117 related articles for article (PubMed ID: 26896816)
1. Statins: An undesirable class of aquatic contaminants?
Santos MM; Ruivo R; Lopes-Marques M; Torres T; de los Santos CB; Castro LF; Neuparth T
Aquat Toxicol; 2016 May; 174():1-9. PubMed ID: 26896816
[TBL] [Abstract][Full Text] [Related]
2. Structural mechanism for statin inhibition of HMG-CoA reductase.
Istvan ES; Deisenhofer J
Science; 2001 May; 292(5519):1160-4. PubMed ID: 11349148
[TBL] [Abstract][Full Text] [Related]
3. Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Istvan ES
Am Heart J; 2002 Dec; 144(6 Suppl):S27-32. PubMed ID: 12486413
[TBL] [Abstract][Full Text] [Related]
4. Explication of interactions between HMGCR isoform 2 and various statins through In silico modeling and docking.
Karthik MV; Satya Deepak MV; Shukla P
Comput Biol Med; 2012 Feb; 42(2):156-63. PubMed ID: 22177940
[TBL] [Abstract][Full Text] [Related]
5. Exploring Leishmania donovani 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) as a potential drug target by biochemical, biophysical and inhibition studies.
Dinesh N; Pallerla DS; Kaur PK; Kishore Babu N; Singh S
Microb Pathog; 2014 Jan; 66():14-23. PubMed ID: 24239940
[TBL] [Abstract][Full Text] [Related]
6. Structure-based rational quest for potential novel inhibitors of human HMG-CoA reductase by combining CoMFA 3D QSAR modeling and virtual screening.
Zhang QY; Wan J; Xu X; Yang GF; Ren YL; Liu JJ; Wang H; Guo Y
J Comb Chem; 2007; 9(1):131-8. PubMed ID: 17206841
[TBL] [Abstract][Full Text] [Related]
7. Recombinant 3-Hydroxy 3-Methyl Glutaryl-CoA Reductase from Candida glabrata (Rec-CgHMGR) Obtained by Heterologous Expression, as a Novel Therapeutic Target Model for Testing Synthetic Drugs.
Andrade-Pavón D; Cuevas-Hernández RI; Trujillo-Ferrara JG; Hernández-Rodríguez C; Ibarra JA; Villa-Tanaca L
Appl Biochem Biotechnol; 2017 Aug; 182(4):1478-1490. PubMed ID: 28138930
[TBL] [Abstract][Full Text] [Related]
8. On the inhibitor effects of bergamot juice flavonoids binding to the 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) enzyme.
Leopoldini M; Malaj N; Toscano M; Sindona G; Russo N
J Agric Food Chem; 2010 Oct; 58(19):10768-73. PubMed ID: 20843083
[TBL] [Abstract][Full Text] [Related]
9. Insight into the mechanism of polyphenols on the activity of HMGR by molecular docking.
Islam B; Sharma C; Adem A; Aburawi E; Ojha S
Drug Des Devel Ther; 2015; 9():4943-51. PubMed ID: 26357462
[TBL] [Abstract][Full Text] [Related]
10. The structure of the catalytic portion of human HMG-CoA reductase.
Istvan ES; Deisenhofer J
Biochim Biophys Acta; 2000 Dec; 1529(1-3):9-18. PubMed ID: 11111074
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis.
Istvan ES; Palnitkar M; Buchanan SK; Deisenhofer J
EMBO J; 2000 Mar; 19(5):819-30. PubMed ID: 10698924
[TBL] [Abstract][Full Text] [Related]
12. Explaining statin inhibition effectiveness of HMG-CoA reductase by quantum biochemistry computations.
da Costa RF; Freire VN; Bezerra EM; Cavada BS; Caetano EW; de Lima Filho JL; Albuquerque EL
Phys Chem Chem Phys; 2012 Jan; 14(4):1389-98. PubMed ID: 22159045
[TBL] [Abstract][Full Text] [Related]
13. The 3-hydroxy-3-methylglutaryl coenzyme-A reductases from fungi: a proposal as a therapeutic target and as a study model.
Andrade-Pavón D; Sánchez-Sandoval E; Rosales-Acosta B; Ibarra JA; Tamariz J; Hernández-Rodríguez C; Villa-Tanaca L
Rev Iberoam Micol; 2014; 31(1):81-5. PubMed ID: 24270073
[TBL] [Abstract][Full Text] [Related]
14. IAF, QGF, and QDF Peptides Exhibit Cholesterol-Lowering Activity through a Statin-like HMG-CoA Reductase Regulation Mechanism: In Silico and In Vitro Approach.
Silva M; Philadelpho B; Santos J; Souza V; Souza C; Santiago V; Silva J; Souza C; Azeredo F; Castilho M; Cilli E; Ferreira E
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681729
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of archaeal HMG-CoA reductase: insights into structural changes of the C-terminal helix of the class-I enzyme.
Vögeli B; Shima S; Erb TJ; Wagner T
FEBS Lett; 2019 Mar; 593(5):543-553. PubMed ID: 30702149
[TBL] [Abstract][Full Text] [Related]
16. Binding thermodynamics of statins to HMG-CoA reductase.
Carbonell T; Freire E
Biochemistry; 2005 Sep; 44(35):11741-8. PubMed ID: 16128575
[TBL] [Abstract][Full Text] [Related]
17. Specific inhibitions of annonaceous acetogenins on class II 3-hydroxy-3-methylglutaryl coenzyme A reductase from Streptococcus pneumoniae.
Feng L; Zhou L; Sun Y; Gui J; Wang X; Wu P; Wan J; Ren Y; Qiu S; Wei X; Li J
Bioorg Med Chem; 2011 Jun; 19(11):3512-9. PubMed ID: 21550257
[TBL] [Abstract][Full Text] [Related]
18. Characterization of an HMG-CoA reductase from Listeria monocytogenes that exhibits dual coenzyme specificity.
Theivagt AE; Amanti EN; Beresford NJ; Tabernero L; Friesen JA
Biochemistry; 2006 Dec; 45(48):14397-406. PubMed ID: 17128979
[TBL] [Abstract][Full Text] [Related]
19. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity.
Staal A; Frith JC; French MH; Swartz J; Güngör T; Harrity TW; Tamasi J; Rogers MJ; Feyen JH
J Bone Miner Res; 2003 Jan; 18(1):88-96. PubMed ID: 12510809
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
Lennernäs H; Fager G
Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]